Archive for the ‘anti-aging’ tag: Page 11
Dec 15, 2017
Bioquark Inc. — School for Startups Radio
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, business, cryonics, DNA, finance, genetics, health
Dec 15, 2017
Bioquark Inc. — CEO in 10 Podcast
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, business, cryonics, DNA, finance, futurism, genetics
Dec 15, 2017
Bioquark Inc. — Health Secrets Made Simple Podcast
Posted by Ira S. Pastor in categories: aging, biological, biotech/medical, cryonics, DNA, genetics, health, life extension, science, transhumanism
Dec 15, 2017
Bioquark Inc. — The Longevity and Biohacking Show
Posted by Ira S. Pastor in categories: aging, biological, business, cryonics, genetics, health, life extension, posthumanism, science, transhumanism
Dec 15, 2017
Bioquark Inc. — Health Professional Radio
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, business, cryonics, DNA, genetics, health, life extension, science, transhumanism
Dec 15, 2017
Bioquark Inc. — The Inner Game Of Aging Podcast
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, cryonics, DNA, genetics, health, life extension, science, transhumanism
Dec 15, 2017
Bioquark Inc. — Happy and Healthy Over 40 Podcast
Posted by Ira S. Pastor in categories: aging, bioengineering, biological, biotech/medical, cryonics, disruptive technology, health, life extension, posthumanism, transhumanism
Jun 29, 2017
Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement
Posted by Ira S. Pastor in categories: aging, bioengineering, biotech/medical, disruptive technology, DNA, genetics, health, life extension, posthumanism, science
Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.
“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”
Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.
Jan 5, 2017
Bioquark Inc. Announces Approval of Bioquantine Food Ingredients in Eurasian Customs Union
Posted by Ira S. Pastor in categories: aging, biotech/medical, business, disruptive technology, food, genetics, health, life extension, science, transhumanism
Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, announced the commercial approval of naturally derived Bioquantine food ingredients in the Eurasian Customs Union (formerly known as the Customs Union of Belarus, Kazakhstan, and Russia). Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, collaborated with Bioquark Inc. on the regulatory approvals.
“We are very excited about this successful regulatory approval,” said Ira S. Pastor, CEO, Bioquark Inc. “The commercialization of Bioquantine food ingredients, including functional foods, drinks, and dietary supplements, represents another important step in our continued evolution as a company focused on a broad range of products and services in the regenerative healthcare space.”
Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.
